Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Posterior Fossa Ependymal Tumor × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 385 Carcinoma, Non-Small-Cell Lung 327 Neoplasms 299 Prostatic Neoplasms 255 Colorectal Neoplasms 199 Lung Neoplasms 195 Neoplasm Metastasis 175 Leukemia, Myeloid, Acute 173 Multiple Myeloma 156 Ovarian Neoplasms 147 Melanoma 125 Pancreatic Neoplasms 113 Squamous Cell Carcinoma of Head and Neck 103 Recurrence 102 Brain Neoplasms 92 Glioblastoma 90 Triple Negative Breast Neoplasms 89 Lymphoma 87 Endometrial Neoplasms 84 Uterine Cervical Neoplasms 82 Glioma 82 Carcinoma, Renal Cell 80 Stomach Neoplasms 79 Precursor Cell Lymphoblastic Leukemia-Lymphoma 79 Carcinoma, Hepatocellular 78 Lymphoma, Non-Hodgkin 76 Urinary Bladder Neoplasms 75 Myelodysplastic Syndromes 71 Sarcoma 69 Lymphoma, Large B-Cell, Diffuse 68

Interventions

Specimen Handling 1 Metformin 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07226453 2026-03-13

PNOC041

University of California, San Francisco

Phase 2 Recruiting

Posterior Fossa Ependymal Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡